Skip to content
Review

Feasibility of a progressive HIIT model of exercise for patients with Type 2 Diabetes Mellitus enrolled in cardiac rehabilitation.

Aug 2026 · Canadian Journal of Diabetes · 0 citations
Medicine

Abstract

A link exists between Type 2 Diabetes Mellitus (T2DM) and developing cardiovascular disease (CVD). Lifestyle interventions targeting T2DM and CVD are required. Cardiac rehabilitation (CR) offers a multidisciplinary approach for management. High-intensity interval training (HIIT) may provide equivalent benefit compared to moderate-intensity continuous exercise (MICE) in improving cardiorespiratory fitness and glycemic control. HIIT should be considered when prescribing exercise for patients with T2DM; however, feasibility research is required. The objective of this study was to determine the feasibility of progressive HIIT in patients with T2DM. Patients in a 24-week CR program provided research consent at 12-weeks. Feasibility was assessed using intervention adherence, drop-out rate/reason, patient satisfaction and safety. Patients completed the HIIT protocol 3-times/week, at 80-95% HRR. Patients started at stage 1 (10x30-sec high intensity:30-sec recovery) and progressed to Stages 2-4 every 3 weeks according to patient desire and achievement of target work rate without adverse events. Possible progressions included Stage-2 (10x1-min high intensity:1-min recovery), Stage-3 (6x2-min high intensity:2-min recovery) and Stage-4 (4x4-min high intensity:3-min recovery). Twenty-two participants consented to participation and seventeen (60.2±12.4-years) completed the program (23% drop-out rate). Adherence to on-site HIIT sessions was 79% and at-home unsupervised sessions was 70%. Five patients (4 females) remained at Stage 1; 4 (2 females) progressed to Stage 2; 7 (2 females) progressed to Stage 3; and one (male) progressed to Stage 4. Satisfaction surveys revealed patients enjoyed HIIT as much as MICE (p=0.29). No HIIT-related adverse events were reported. Progressive HIIT is feasible, enjoyable, and safe among patients with T2DM.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.